Glaukos Corp (NYSE:GKOS) Moving Aggressively - Down $2.86

There has been some selling insider activity on Glaukos Corp (NYSE:GKOS) recently. Whereas 0 of them predict the stock is a hold.

The analysts wrote, "Executing Well in a Slightly Adverse Environment". More interesting news about Glaukos Corp (NYSE:GKOS) were released by: and their article: "Glaukos' (GKOS) CEO Thomas Burns on Q3 2017 Results - Earnings Call Transcript" published on November 08, 2017 as well as's news article titled: "Is It Too Late To Buy Glaukos Corporation (GKOS)?" with publication date: September 14, 2017. The company reported to be on track to have trained 3,000 surgeons by YE17. Glaukos Corporation has a 12-month low of $26.44 and a 12-month high of $52.49. Long term, we believe Glaukos' iStent has demonstrated significant long-term benefit and cost efficiency to maintain a commercial and competitive advantage. On September 14, 2017 Stifel Nicolaus kept a "Buy" rating on the company. BidaskClub downgraded shares of Glaukos Corporation from a "hold" rating to a "sell" rating in a research note on Saturday, August 26th.

The top 5 institutional holders, in ascending order, are as follows: JANUS HENDERSON GROUP PLC with 3.34 million shares, CAPITAL WORLD INVESTORS with 2.74 million shares, DEERFIELD MANAGEMENT CO with 2.53 million shares, PRICE T ROWE ASSOCIATES INC /MD/ with 2.27 million shares, and BAMCO INC /NY/ with 2.19 million shares.

BMO Capital Markets lowered the price target on November 8 cutting the projection from $45.00 to $40.00 and issued a "Outperform" rating. BMO Capital Markets maintained the stock with "Buy" rating in Wednesday, April 12 report. Cantor Fitzgerald reiterated a "buy" rating and issued a $60.00 target price on shares of Glaukos Corporation in a research note on Tuesday, November 7th.

Glaukos Corp (NYSE:GKOS) has grabbed attention from the analysts, when it saw a value increase of 6.65% or 1.76 points in the last trading session to close at $28.21. The stock had a trading volume of 1,684,136 shares, compared to its average volume of 631,841.

According to Glaukos Corporation (GKOS) most recent 13F filing, the company has 13 new institutional holders - accounting for 378,040 shares of its common stock.

They now have a $40 target on Glaukos (NYSE:GKOS). As of the last earnings report the EPS was $-0.03 with 34.57M shares presently outstanding. The company now has a Return on Equity of -0.8% and a Return on Investment of 3.6%. The company had revenue of $40.41 million during the quarter, compared to analysts' expectations of $38.69 million. During the same period in the prior year, the company earned $0.03 earnings per share.

Analysts await Glaukos Corp (NYSE:GKOS) to report earnings on March, 7. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and global trademark & copyright legislation. The original version of this news story can be read at Advisors Llc Orbimed, Director disclosed the sale of 580,200 shares of (GKOS). Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance.

In related news, CEO Thomas William Burns sold 1,212 shares of the company's stock in a transaction on Tuesday, September 5th. These shares are 55.55% off its target price of $43.88 and the current market capitalization stands at $998.07M. The disclosure for this sale can be found here. In the last three months, insiders sold 655,200 shares of company stock valued at $25,573,013.

Several equities analysts have recently weighed in on the stock. Shaker Investments LLC OH increased its stake in shares of Glaukos Corporation by 6.3% in the third quarter. Bamco Inc. NY boosted its stake in Glaukos Corporation by 104.6% in the 3rd quarter. Shaker Investments LLC OH now owns 47,025 shares of the medical instruments supplier's stock worth $1,552,000 after purchasing an additional 2,800 shares in the last quarter. Schwab Charles Investment Management Inc. increased its position in Glaukos Corporation by 48.2% during the second quarter. First Republic Investment Management Inc. now owns 8,300 shares of the medical instruments supplier's stock valued at $274,000 after purchasing an additional 2,659 shares during the last quarter. The total number of shares traded in the last 90-day period is 1.24 million.

The insider now holds 16,128 shares of Glaukos Corporation (GKOS). The Firm focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm's canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream.

Like this



22 November 2017
Ben Domenech Latest News, Photos, and Videos
After the ceremony, McCain and Domenech celebrated with dinner and dancing with 100 close friends, family and former colleagues. McCain revealed in September that doctors gave him a "poor prognosis" in his fight with brain cancer.

22 November 2017
Kratos Defense & Security Solutions, Inc. (KTOS) Releases Quarterly Earnings Results, Meets Expectations
S Squared Technology Llc holds 17.54% of its portfolio in Kratos Defense & Security Solutions, Inc for 1.73 million shares. Kratos Defense & Security Solutions, Inc ( KTOS ) has risen 142.79% since November 21, 2016 and is uptrending.

22 November 2017
Burning Stock on the move: Novavax, Inc. (NVAX)
As of the end of the quarter Panagora Asset Management Inc had disposed of 834,048 shares trimming its holdings by 35.9%. Following the completion of the transaction, the insider now owns 228,279 shares in the company, valued at $257,955.27.

22 November 2017
Tactile Systems Technology, Inc. (TCMD) CEO Sells 21613 Shares of Stock
Insiders contain to comply with strict disclosure requirements with regard to the sale or purchase of the shares of their company. Cadence Capital Management LLC grew its holdings in shares of Tactile Systems Technology by 5.1% during the 3rd quarter.

22 November 2017
Industry withheld evidence of sugar's negative health effects 50 years ago: paper
But critics argue that the industry is still trying to slow down the consensus on the health risks linked to sugar consumption. The Sugar Association, the industry's trade group, didn't immediately return a message seeking comment Tuesday afternoon.

22 November 2017
It's Cheaper to Ship Camrys From Japan Than Make Them in US
The plant has a contingent of employees who have been pushing for a representation vote at the facility. Brian Rothenberg, a Detroit-based spokesman for the UAW, said he had no immediate comment.

22 November 2017
First Western Capital Management Co Reduces Stake in Johnson & Johnson (JNJ)
After $0.20 actual EPS reported by Monsanto Company for the previous quarter, Wall Street now forecasts 90.00% EPS growth. The stock of Atlantic Power Corp (NYSE:AT) earned "Sector Perform" rating by RBC Capital Markets on Wednesday, March 9.

22 November 2017
Omega Healthcare Investors, Inc. (NYSE:OHI) Director Buys $2824000.00 in Stock
Wellington Management Group LLP increased its holdings in shares of Omega Healthcare Investors by 482.5% during the first quarter. ValuEngine cut Omega Healthcare Investors from a "buy" rating to a "hold" rating in a research note on Wednesday, September 6th.

22 November 2017
Vikings' Case Keenum playing with big ... fortitude, Mike Zimmer says
Detroit's defense held Keenum to a season-low 53 percent completion rate; he finished without a touchdown pass in that game. Keenum, taken down just five times this season, is the least-sacked quarterback in the NFL.

22 November 2017
Cipher Capital LP Has $6.29 Million Holdings in Oracle Corporation (ORCL)
Also, Director Hector Garcia-Molina sold 3,750 shares of Oracle Corporation stock in a transaction dated Friday, September 15th. Short traders are feeling a little more bearish on shares of the company if you put credence in the uptick in short interest.